(Q38957840)

8 September 2017

1 reference

title

Interleukin-33 in health and disease (English)

1 reference

8 September 2017

Foo Yew Liew

1

1 reference

8 September 2017

Jean-Philippe Girard

series ordinal

2

1 reference

8 September 2017

Heth Roderick Turnquist

series ordinal

3

1 reference

8 September 2017

publication date

19 September 2016

1 reference

Nature Reviews Immunology

8 September 2017

published in

1 reference

8 September 2017

volume

16

1 reference

8 September 2017

issue

11

1 reference

8 September 2017

page(s)

676-689

1 reference

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

A large-scale, consortium-based genomewide association study of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

The mouse interleukin (Il)33 gene is expressed in a cell type- and stimulus-dependent manner from two alternative promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors--insight into heterotrimeric IL-1 signaling complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Structural insights into the interaction of IL-33 with its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

The dual function cytokine IL-33 interacts with the transcription factor NF-κB to dampen NF-κB-stimulated gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

The glia-derived alarmin IL-33 orchestrates the immune response and promotes recovery following CNS injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Interleukin-33 is biologically active independently of caspase-1 cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

A critical role of IL-33 in experimental allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Induction of IL-33 expression and activity in central nervous system glia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Myocardial pressure overload induces systemic inflammation through endothelial cell IL-33.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Interleukin 33 as a mechanically responsive cytokine secreted by living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 amplifies an innate immune response in the degenerating retina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Unique temporal and spatial expression patterns of IL-33 in ovaries during ovulation and estrous cycle are associated with ovarian tissue homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 citrine reporter mice reveal the temporal and spatial expression of IL-33 during allergic lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

The IL-33/ST2 axis augments effector T-cell responses during acute GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Interleukin-33 overexpression is associated with liver fibrosis in mice and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Nuclear expression of interleukin-33 in pancreatic stellate cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33, but not IL-25, is crucial for the development of house dust mite antigen-induced allergic rhinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Group 2 innate lymphoid cells utilize the IRF4-IL-9 module to coordinate epithelial cell maintenance of lung homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

AMCase is a crucial regulator of type 2 immune responses to inhaled house dust mites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Caspase-1 activation by NLRP3 inflammasome dampens IL-33-dependent house dust mite-induced allergic lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Contradictory functions (activation/termination) of neutrophil proteinase 3 enzyme (PR3) in interleukin-33 biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

New dog and new tricks: evolving roles for IL-33 in type 2 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 is an unconventional Alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R/ST2+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Peri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Antigen- and cytokine-driven accumulation of regulatory T cells in visceral adipose tissue of lean mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

A Distinct Function of Regulatory T Cells in Tissue Protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

The alarmin IL-33 promotes regulatory T-cell function in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

A special population of regulatory T cells potentiates muscle repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Systemically dispersed innate IL-13-expressing cells in type 2 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

The transcription factor GATA3 is critical for the development of all IL-7Rα-expressing innate lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Innate lymphoid cells--a proposal for uniform nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

The brave new world of innate lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-1beta-driven ST2L expression promotes maturation resistance in rapamycin-conditioned dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33-activated dendritic cells induce an atypical TH2-type response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Expression and function of the ST2 gene in a murine model of allergic airway inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

An Interleukin-33-Mast Cell-Interleukin-2 Axis Suppresses Papain-Induced Allergic Inflammation by Promoting Regulatory T Cell Numbers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

T-bet- and STAT4-dependent IL-33 receptor expression directly promotes antiviral Th1 cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Expression of ST2, an interleukin-1 receptor homologue, is induced by proinflammatory stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

F-box protein FBXL19-mediated ubiquitination and degradation of the receptor for IL-33 limits pulmonary inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Exosomes secreted by nematode parasites transfer small RNAs to mammalian cells and modulate innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33, a potent inducer of adaptive immunity to intestinal nematodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookworms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

A late IL-33 response after exposure to Schistosoma haematobium antigen is associated with an up-regulation of IL-13 in human eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Regulation of type 2 immunity to helminths by mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Chitin activates parallel immune modules that direct distinct inflammatory responses via innate lymphoid type 2 and γδ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Combinatorial targeting of TSLP, IL-25, and IL-33 in type 2 cytokine-driven inflammation and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Immunological regulation of experimental cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Organ-specific distribution of CD4+ T1/ST2+ Th2 cells in Leishmania major infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 receptor (T1/ST2) signalling is necessary to prevent the development of encephalitis in mice infected with Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Proinflammatory and regulatory cytokines and chemokines in infants with uncomplicated and severe Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33-mediated protection against experimental cerebral malaria is linked to induction of type 2 innate lymphoid cells, M2 macrophages and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

T1/ST2 promotes T helper 2 cell activation and polyfunctionality in bronchopulmonary mycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 signaling regulates innate and adaptive immunity to Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Soluble ST2 plasma concentrations predict mortality in severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Interleukin-33 increases antibacterial defense by activation of inducible nitric oxide synthase in skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 Exacerbates Periodontal Disease through Induction of RANKL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 shifts macrophage polarization, promoting resistance against Pseudomonas aeruginosa keratitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 promotes Staphylococcus aureus-infected wound healing in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Immunosuppression in patients who die of sepsis and multiple organ failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

The late phase of sepsis is characterized by an increased microbiological burden and death rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Elevated levels of soluble ST2 protein in dengue virus infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Inhibition of T1/ST2 during respiratory syncytial virus infection prevents T helper cell type 2 (Th2)- but not Th1-driven immunopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Mast cells play a key role in host defense against herpes simplex virus infection through TNF-α and IL-6 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

The IL-33/ST2 pathway controls coxsackievirus B5-induced experimental pancreatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 reduces the development of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Genetic variant in IL33 is associated with susceptibility to rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

A novel therapy of murine collagen-induced arthritis with soluble T1/ST2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 exacerbates antigen-induced arthritis by activating mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

MicroRNA29a regulates IL-33-mediated tissue remodelling in tendon disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Poor Repair of Skeletal Muscle in Aging Mice Reflects a Defect in Local, Interleukin-33-Dependent Accumulation of Regulatory T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 is a crucial amplifier of innate rather than acquired immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Interleukin-33 ameliorates experimental colitis through promoting Th2/Foxp3⁺ regulatory T-cell responses in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 is negatively associated with the BMI and confers a protective lipid/metabolic profile in non-diabetic but not diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Activated type 2 innate lymphoid cells regulate beige fat biogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 attenuates the development of experimental autoimmune uveitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 activates tumor stroma to promote intestinal polyposis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Interleukin-33 prolongs allograft survival during chronic cardiac rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Elevated ST2 Distinguishes Incidences of Pediatric Heart and Small Bowel Transplant Rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

ST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Soluble ST2 is a marker for acute cardiac allograft rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Regulatory T cells suppress muscle inflammation and injury in muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33-Dependent Group 2 Innate Lymphoid Cells Promote Cutaneous Wound Healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Interleukin-33 potentiates bleomycin-induced lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Production and functions of IL-33 in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Interleukin-33 ameliorates ischemic brain injury in experimental stroke through promoting Th2 response and suppressing Th17 response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Interleukin-33 treatment reduces secondary injury and improves functional recovery after contusion spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Early cerebrovascular inflammation in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Primary sources and immunological prerequisites for sST2 secretion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

ST2 receptor invalidation maintains wound inflammation, delays healing and increases fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

The alarmin interleukin-33 drives protective antiviral CD8⁺ T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33-mediated innate response and adaptive immune cells contribute to maximum responses of protease allergen-induced allergic airway inflammation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 and ST2 in Atopic Dermatitis: Expression Profiles and Modulation by Triggering Factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33-activated dendritic cells are critical for allergic airway inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Immunity toToxoplasma gondii- into the 21st century

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 priming regulates multiple steps of the neutrophil-mediated anti-Candida albicans response by modulating TLR and dectin-1 signals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Loss of Suppression of Tumorigenicity 2 (ST2) Gene Reverses Sepsis-induced Inhibition of Lung Host Defense in Mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

High levels of soluble ST2 and low levels of IL-33 in sera of patients with HIV infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Association of serum interleukin-33 level and the interleukin-33 genetic variant with Japanese cedar pollinosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 Exacerbates Eosinophil-Mediated Airway Inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Serum levels of IL-33 is increased in patients with ankylosing spondylitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

IL-33 Activates B1 Cells and Exacerbates Contact Sensitivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: effects in CD4(+) -cell depleted, athymic and NK-cell depleted SCID mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

BCR-ABL-induced deregulation of the IL-33/ST2 pathway in CD34+ progenitors from chronic myeloid leukemia patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.95

Inflammatory group 2 innate lymphoid cells

31 March 2020

1 reference

12 December 2020

Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii.

1 reference

12 December 2020

Implication of IL-33 gene polymorphism in Chinese patients with Alzheimer's disease

1 reference

12 December 2020

Increased IL-33 in synovial fluid and paired serum is associated with disease activity and autoantibodies in rheumatoid arthritis

1 reference

12 December 2020

Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRI.2016.95

1 reference

8 September 2017

1 reference